Literature DB >> 10847487

Expression of cyclin D1, cyclin E, cdk4 and loss of heterozygosity of 8p, 13q, 17p in hepatocellular carcinoma: comparison study of childhood and adult hepatocellular carcinoma.

H Kim1, M J Lee, M R Kim, I P Chung, Y M Kim, J Y Lee, J J Jang.   

Abstract

AIMS/
BACKGROUND: In hepatitis B virus-related hepatocellular carcinoma (HCC), at least 20-40 years of continuous necro-inflammation is necessary for the hepato-carcinogenesis to occur. However, HCC in childhood shows an unusually short latent period and rapid progression. In our previous report, mutation of c-met was found only in childhood HCC, but not in adult HCC. In order to determine the specific biological tumorous features of childhood HCC, a comparison study of childhood and adult HCC was performed.
METHODS: Eighteen cases of HBV positive HCC (nine children and nine adults aged more than 40 years) were selected. The expression of G1 phase regulatory proteins (cyclin D1, cyclin E and cdk4) was studied using immunohistochemical methods. Loss of heterozygosity (LOH) on chromosomal arms 8p, 13q and 17p was analyzed.
RESULTS: Cyclin D1 expression was significantly lower in childhood HCC than in adult HCC (cases of cyclin D1 expression under 3+: childhood 5/9 vs. adult 1/9, p=0.046). No difference in cyclin E and cdk4 expression was found between childhood and adult HCC. LOH frequency on 13q was relatively higher in childhood than in adult HCC (66.7% vs. 22.2%, p=0.058). LOH frequency on 8p and 17p was 44.4% and 33.3% in childhood HCC and 44.4% and 75% in adult HCC with no statistical significance between the two groups.
CONCLUSION: Our data suggest that childhood HCC may be less dependent on cyclin D1 protein for tumor growth and progression than adult HCC, and that the LOH on 13q may be an important feature of childhood HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10847487     DOI: 10.1034/j.1600-0676.2000.020002173.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  12 in total

1.  Transactivating effect of complete S protein of hepatitis B virus and cloning of genes transactivated by complete S protein using suppression subtractive hybridization technique.

Authors:  Gui-Qin Bai; Yan Liu; Jun Cheng; Shu-Lin Zhang; Ya-Fei Yue; Yan-Ping Huang; Li-Ying Zhang
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

2.  Effects of hepatitis B virus infection on human sperm chromosomes.

Authors:  Jian-Min Huang; Tian-Hua Huang; Huan-Ying Qiu; Xiao-Wu Fang; Tian-Gang Zhuang; Hong-Xi Liu; Yong-Hua Wang; Li-Zhi Deng; Jie-Wen Qiu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

Review 3.  Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.

Authors:  Matthew P Lungren; Alexander J Towbin; Derek J Roebuck; Eric J Monroe; Anne E Gill; Avnesh Thakor; Richard B Towbin; Anne Marie Cahill; C Matthew Hawkins
Journal:  Pediatr Radiol       Date:  2018-01-23

4.  Characterisation of the cell line HC-AFW1 derived from a pediatric hepatocellular carcinoma.

Authors:  Sorin Armeanu-Ebinger; Julia Wenz; Guido Seitz; Ivo Leuschner; Rupert Handgretinger; Ulrike A Mau-Holzmann; Michael Bonin; Bence Sipos; Jörg Fuchs; Steven W Warmann
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

5.  Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.

Authors:  Cheng-Rong Xie; Zhao Li; Hong-Guang Sun; Fu-Qiang Wang; Yu Sun; Wen-Xiu Zhao; Sheng Zhang; Wen-Xing Zhao; Xiao-Min Wang; Zhen-Yu Yin
Journal:  Oncotarget       Date:  2015-12-01

6.  Effects of curcumin in pediatric epithelial liver tumors: inhibition of tumor growth and alpha-fetoprotein in vitro and in vivo involving the NFkappaB- and the beta-catenin pathways.

Authors:  Nicola Bortel; Sorin Armeanu-Ebinger; Evi Schmid; Bettina Kirchner; Jan Frank; Alexa Kocher; Christina Schiborr; Steven Warmann; Jörg Fuchs; Verena Ellerkamp
Journal:  Oncotarget       Date:  2015-12-01

7.  The association of adverse outcomes in the mother with disease progression in offspring in families with clusters of hepatitis B virus infection and unfavorable prognoses in Northwest China.

Authors:  Yuan Yang; Li Jin; Zhen Tian; Dandan Guo; Naijuan Yao; Qian Li; Zicheng Jiang; Daokun Yang; Xianmei Tang; Hongbin Li; Yingli He; Jinfeng Liu; Tianyan Chen; Yingren Zhao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

8.  Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma.

Authors:  Ying Zhu; Kun-Bin Ke; Zhong-Kun Xia; Hong-Jian Li; Rong Su; Chao Dong; Feng-Mei Zhou; Lin Wang; Rong Chen; Shi-Guo Wu; Hui Zhao; Peng Gu; Kwong-Sak Leung; Man-Hon Wong; Gang Lu; Jian-Ying Zhang; Bing-Hua Jiang; Jian-Ge Qiu; Xi-Nan Shi; Marie Chia-Mi Lin
Journal:  Mol Med       Date:  2021-02-12       Impact factor: 6.354

Review 9.  Pediatric hepatocellular carcinoma.

Authors:  Rajeev Khanna; Sanjeev Kumar Verma
Journal:  World J Gastroenterol       Date:  2018-09-21       Impact factor: 5.742

10.  Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma.

Authors:  Zhong-Kun Xia; Wei Wang; Jian-Ge Qiu; Xi-Nan Shi; Hong-Jian Li; Rong Chen; Kun-Bin Ke; Chao Dong; Ying Zhu; Shi-Guo Wu; Rong-Ping Zhang; Zhuo-Ran Meng; Hui Zhao; Peng Gu; Kwong-Sak Leung; Man-Hon Wong; Xiao-Dong Liu; Feng-Mei Zhou; Jian-Ying Zhang; Ya-Ting Yao; Si-Jia Wang; Chun-Yang Zhang; Yan-Ru Qin; Marie Chia-Mi Lin; Bing-Hua Jiang
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.